$30.75
arrow_drop_up0.22%Key Stats | |
---|---|
Open | $29.76 |
Prev. Close | $29.90 |
EPS | -0.29 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 29.76 | 30.66 |
52 Week Range | 21.99 | 35.44 |
Ratios | |
---|---|
EPS | -0.29 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Supernus Pharmaceuticals to Announce Second Quarter 2024 - GlobeNewswire
Do Options Traders Know Something About Supernus (SUPN) Stock We Don't?
Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics
Supernus Announces First Quarter 2024 Financial Results
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.